These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 24500562)

  • 1. MicroRNAs: the underlying mediators of pathogenetic processes in vascular complications of diabetes.
    Ruiz MA; Chakrabarti S
    Can J Diabetes; 2013 Oct; 37(5):339-44. PubMed ID: 24500562
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hereditary factors in the development of diabetic renal disease.
    Marre M; Hadjadj S; Bouhanick B
    Diabetes Metab; 2000 Jul; 26 Suppl 4():30-6. PubMed ID: 10922971
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MicroRNAs: potential therapeutic targets in diabetic complications of the cardiovascular and renal systems.
    Figueira MF; Monnerat-Cahli G; Medei E; Carvalho AB; Morales MM; Lamas ME; da Fonseca RN; Souza-Menezes J
    Acta Physiol (Oxf); 2014 Jul; 211(3):491-500. PubMed ID: 24837225
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MicroRNA 21 Emerging Role in Diabetic Complications: A Critical Update.
    Roy D; Modi A; Khokhar M; Sankanagoudar S; Yadav D; Sharma S; Purohit P; Sharma P
    Curr Diabetes Rev; 2021; 17(2):122-135. PubMed ID: 32359340
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Renoprotection in diabetes: genetic and non-genetic risk factors and treatment.
    Parving HH
    Diabetologia; 1998 Jul; 41(7):745-59. PubMed ID: 9686914
    [No Abstract]   [Full Text] [Related]  

  • 6. Improving microvascular outcomes in patients with diabetes through management of hypertension.
    McGill JB
    Postgrad Med; 2009 Mar; 121(2):89-101. PubMed ID: 19332966
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Study of microRNA in diabetic nephropathy: isolation, quantification and biological function.
    Kantharidis P; Hagiwara S; Brennan E; McClelland AD
    Nephrology (Carlton); 2015 Mar; 20(3):132-9. PubMed ID: 25487691
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chronic complications of diabetes: a creative management approach.
    Eaks GA; Tiszka R
    Nurse Pract Forum; 1998 Jun; 9(2):74-86. PubMed ID: 9752122
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MicroRNAs in diabetes and diabetes-associated complications.
    Lorenzen J; Kumarswamy R; Dangwal S; Thum T
    RNA Biol; 2012 Jun; 9(6):820-7. PubMed ID: 22664916
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Meta-analysis of association of insertion/deletion polymorphism of angiotensin I-converting enzyme gene with diabetic nephropathy and retinopathy.
    Fujisawa T; Ikegami H; Kawaguchi Y; Hamada Y; Ueda H; Shintani M; Fukuda M; Ogihara T
    Diabetologia; 1998 Jan; 41(1):47-53. PubMed ID: 9498629
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of microRNAs in the modulation of diabetic retinopathy.
    Mastropasqua R; Toto L; Cipollone F; Santovito D; Carpineto P; Mastropasqua L
    Prog Retin Eye Res; 2014 Nov; 43():92-107. PubMed ID: 25128741
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Cardiovascular autonomic neuropathy and nephropathy in patients with type-1 diabetes mellitus].
    Galicka-Latała D; Fedak D; Kuźniewski M; Kawalec E; Solnica B
    Przegl Lek; 2004; 61(3):155-8. PubMed ID: 15518324
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Retinopathy and nephropathy in 772 insulin-treated diabetic patients in relation to the type of diabetes.
    Schmechel H; Heinrich U
    Diabete Metab; 1993; 19(1 Pt 2):138-42. PubMed ID: 8314417
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genetics of diabetic complications.
    Alcolado J
    Lancet; 1998 Jan; 351(9098):230-1. PubMed ID: 9457089
    [No Abstract]   [Full Text] [Related]  

  • 15. Vascular complications in diabetic pregnancy.
    Kaaja R
    Thromb Res; 2011 Feb; 127 Suppl 3():S53-5. PubMed ID: 21262442
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MicroRNA-dependent cross-talk between VEGF and HIF1α in the diabetic retina.
    Ling S; Birnbaum Y; Nanhwan MK; Thomas B; Bajaj M; Ye Y
    Cell Signal; 2013 Dec; 25(12):2840-7. PubMed ID: 24018047
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of risk factors for the development of nephropathy in patients with IDDM: insertion/deletion angiotensin converting enzyme gene polymorphism, hypertension and metabolic control.
    Barnas U; Schmidt A; Illievich A; Kiener HP; Rabensteiner D; Kaider A; Prager R; Abrahamian H; Irsigler K; Mayer G
    Diabetologia; 1997 Mar; 40(3):327-31. PubMed ID: 9084972
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MicroRNA: A new generation therapeutic target in diabetic nephropathy.
    Dewanjee S; Bhattacharjee N
    Biochem Pharmacol; 2018 Sep; 155():32-47. PubMed ID: 29940170
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long-term results of the Kumamoto Study on optimal diabetes control in type 2 diabetic patients.
    Shichiri M; Kishikawa H; Ohkubo Y; Wake N
    Diabetes Care; 2000 Apr; 23 Suppl 2():B21-9. PubMed ID: 10860187
    [TBL] [Abstract][Full Text] [Related]  

  • 20. microRNA in the development of diabetic complications.
    McClelland AD; Kantharidis P
    Clin Sci (Lond); 2014 Jan; 126(2):95-110. PubMed ID: 24059587
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.